New Perspectives on Treating Early-Stage Alzheimerls
15-Dec-06

At a recent standalone symposium in Seoul, Korea, Alzheimer’s researchers spoke about emerging treatment options for the early stages of this debilitating disease.

Click here to read more

Recent Benefits of EGb 761® (Standardized Ginkgo biloba extract) in Prevention of Dementia
15-Dec-06

It has been a century since Alzheimer’s disease (AD) was first described in 1906, and it has become the most prevalent cause of dementia wroldwide. ...In Europe and the United States, various cerebral and peripheral vasotherapeutic agents - classified in Europe as C4A agents - are used to treat memory impairment in the elderly, and have the potential for preventing a decline in cognitive function. One of these agents is a special standardized Ginkgo biloba extract: EGb 761®.... Recently, a number of studies have further explored this potential role of EGb 761®.

Click here to read more

Managing community-acquired UTI
1-Oct-06

Approximately 5% of women will present with at least one episode of urinary tract infection (UTI) by 20 years of age. A local survey revealed that the average GP sees four to eight UTI cases a month, of which about 80% are women. Most patients are treated empirically based on urine dipstick findings... Although empirical treatment without urine culture is wide-spread and acceptable in general practice, this practice has its drawbacks.

Click here to read more

Compliance important in treating UUTIs
1-Oct-05

... Uncomplicated urinary tract infections (UUTIs), which are common in young women, are often troublesome and bothersome. Patients often do not finish their course of antibiotics once their urinary symptoms are relieved. They might also switch to another antibiotic if rapid symptomatic relief is not obtained, said Associate Professor Dr. Chua Chong Beng, a consultant urologist from Univerisity of Malaya Medical Centre in an interview with Medical Tribune newspaper.

Hence, ease of dosing, which increases compliance, should be considered when selecting an antibiotic for UUTI.

Click here to read more

New campaign delves into diabetes disabilities
1-Oct-05

Diabetes has become a national diability, according to the director of the National Diabetes Institute (NADI), and with numbers rising, it is important for Malaysian doctors to detect and treat its complications more aggressively.

Speaking to this newspaper about the significance of the recently launched V-Protect campaign - an Emerging Pharma-sponsored incentive aimed at increasing awareness for microalbuminuria testing - NADI director and endocrinologist Dato’ Professor Mustaffa Embong stressed that early detection and intervention are essential to slowing the macrovascular problems that occur with diabetes.

Click here to read more